ConductScience.org, home

Paper147116

Fast-acting plasmin inhibitor in human plasma.

Collen D and 1 other. Blood, 1978. Cited by 68 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Fast-acting plasmin inhibitor in human plasma. Papers, record 147116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/147116

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fast-acting plasmin inhibitor in human plasma.
PubMed
Journal
Blood
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.2
iCite
Revised in PubMed
2021-02-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Collen DD
2Wiman BB

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrinolysinMajor topic
Cell Transformation, Neoplastic
Chemical Phenomena
Chemistry
Chromatography, Affinity
Chromatography, Gel
Esterases
Female
Fibrinolysis
Glycoproteins
Humans
Male
Peptide Hydrolases
Time Factors

Source PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
40,867,572Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure.Biomolecules2025https://conductscience.org/library/papers/40867572PubMed
39,299,614Bivariate genome-wide association study of circulating fibrinogen and C-reactive protein levels.J Thromb Haemost2024https://conductscience.org/library/papers/39299614PubMed
36,759,279Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.J Thromb Haemost2023https://conductscience.org/library/papers/36759279PubMed
35,986,069Alterations in the kallikrein-kinin system predict death after heart transplant.Sci Rep2022https://conductscience.org/library/papers/35986069PubMed
33,426,005Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.Front Cardiovasc Med2020https://conductscience.org/library/papers/33426005PubMed
30,429,724Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure.EJIFCC2001https://conductscience.org/library/papers/30429724PubMed
29,294,343Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.Neuroscience2018https://conductscience.org/library/papers/29294343PubMed
28,710,283Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.J Biol Chem2017https://conductscience.org/library/papers/28710283PubMed
24,383,758Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.Biochemistry2014https://conductscience.org/library/papers/24383758PubMed
21,700,944Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.Stroke2011https://conductscience.org/library/papers/21700944PubMed
7,276,224Concentration of plasminogen and antiplasmin in plasma and serum.J Clin Pathol1981https://conductscience.org/library/papers/7276224PubMed
7,199,538Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.J Clin Invest1982https://conductscience.org/library/papers/7199538PubMed
6,907,016Affinity-chromatographic purification of human alpha 2-antiplasmin.Biochem J1980https://conductscience.org/library/papers/6907016PubMed
6,291,058Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6291058PubMed
3,115,654A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).Clin Exp Immunol1987https://conductscience.org/library/papers/3115654PubMed
2,445,779alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.J Clin Invest1987https://conductscience.org/library/papers/2445779PubMed
293,745Structural studies of human IgD: isolation by a two-step purification procedure and characterization by chemical and enzymatic fragmentation.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/293745PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PLG5,340PubTator's text mininghttps://conductscience.org/library/genes/5340

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/147116

GET https://conductscience.org/api/papers/v1/147116/authors